
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $580.5M | $1B | $2.1B | $3.1B | $5B | |
Revenue Growth (YoY) | -38.53% | 77.43% | 106.94% | 46.43% | 60.23% | |
Cost of Revenues | $539.1M | $481.4M | $714.5M | $1.5B | $2.6B | |
Gross Profit | $41.3M | $548.5M | $1.4B | $1.7B | $2.4B | |
Gross Profit Margin | 7.12% | 53.25% | 66.48% | 52.88% | 47.1% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $72.9M | $110.5M | $159.6M | $161.9M | $174.6M | |
Other Inc / (Exp) | -$651.2M | -$230.1M | -$280.1M | -$256.2M | -$302.8M | |
Operating Expenses | $91.2M | $118.3M | $170.9M | $181.2M | $205.4M | |
Operating Income | -$49.9M | $430.1M | $1.2B | $1.5B | $2.1B | |
Net Interest Expenses | $69.2M | $61.3M | $95.6M | $177.2M | $296.2M | |
EBT. Incl. Unusual Items | -$770.3M | $138.7M | $870.1M | $1B | $1.6B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$85.1M | $569K | $120.3M | $155.9M | $300.3M | |
Net Income to Company | -$685.2M | $138.2M | $749.8M | $879.7M | $1.3B | |
Minority Interest in Earnings | $2.4M | -- | -$234.8M | -$403.4M | -$265.8M | |
Net Income to Common Excl Extra Items | -$682.8M | $138.2M | $515M | $476.3M | $984.7M | |
Basic EPS (Cont. Ops) | -$2.46 | $0.49 | $1.80 | $1.36 | $1.54 | |
Diluted EPS (Cont. Ops) | -$2.46 | $0.46 | $1.61 | $1.24 | $1.45 | |
Weighted Average Basic Share | $277.4M | $280.9M | $286.2M | $349.2M | $640.7M | |
Weighted Average Diluted Share | $277.4M | $310.2M | $322.8M | $389.1M | $684.5M | |
EBITDA | -$342.6M | $489.2M | $1.4B | $2.2B | $3.6B | |
EBIT | -$701.1M | $200M | $965.8M | $1.2B | $1.8B | |
Revenue (Reported) | $580.5M | $1B | $2.1B | $3.1B | $5B | |
Operating Income (Reported) | -$49.9M | $430.1M | $1.2B | $1.5B | $2.1B | |
Operating Income (Adjusted) | -$701.1M | $200M | $965.8M | $1.2B | $1.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $192.4M | $347.3M | $616.3M | $1.2B | $1.4B | |
Revenue Growth (YoY) | -0.2% | 80.51% | 77.46% | 101.7% | 10.74% | |
Cost of Revenues | $110.3M | $121.6M | $278.2M | $617.9M | $700.5M | |
Gross Profit | $82.1M | $225.6M | $338M | $625.1M | $676M | |
Gross Profit Margin | 42.69% | 64.98% | 54.85% | 50.29% | 49.11% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $25.6M | $31M | $36.6M | $37.4M | $43.1M | |
Other Inc / (Exp) | -$72.9M | -$157M | -$7.4M | -$225.1M | -$52.9M | |
Operating Expenses | $26.4M | $32.9M | $39.8M | $48.9M | $58.3M | |
Operating Income | $55.8M | $192.7M | $298.2M | $576.2M | $617.7M | |
Net Interest Expenses | $17.5M | $13.2M | $36.8M | $72.6M | $73.8M | |
EBT. Incl. Unusual Items | -$34.6M | $22.6M | $254.1M | $278.6M | $490.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $6.8M | $34.3M | $49M | $100.3M | |
Net Income to Company | -$34.6M | $15.8M | $219.8M | $229.6M | $390.6M | |
Minority Interest in Earnings | -- | -- | -$117.7M | -$83M | -$61.3M | |
Net Income to Common Excl Extra Items | -$34.6M | $15.8M | $102.1M | $146.6M | $329.3M | |
Basic EPS (Cont. Ops) | -$0.12 | $0.06 | $0.35 | $0.27 | $0.47 | |
Diluted EPS (Cont. Ops) | -$0.12 | $0.05 | $0.31 | $0.25 | $0.44 | |
Weighted Average Basic Share | $278.9M | $284.9M | $295.9M | $552.5M | $704M | |
Weighted Average Diluted Share | $278.9M | $319.7M | $335.8M | $595.4M | $748.2M | |
EBITDA | $44.8M | $105.2M | $476.3M | $759.8M | $1B | |
EBIT | -$19M | $34.2M | $288M | $349.6M | $562.6M | |
Revenue (Reported) | $192.4M | $347.3M | $616.3M | $1.2B | $1.4B | |
Operating Income (Reported) | $55.8M | $192.7M | $298.2M | $576.2M | $617.7M | |
Operating Income (Adjusted) | -$19M | $34.2M | $288M | $349.6M | $562.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $580.1M | $1.2B | $2.4B | $3.7B | $5.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $498.6M | $492.8M | $871.1M | $1.8B | $2.7B | |
Gross Profit | $81.5M | $692M | $1.5B | $1.9B | $2.4B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $78.7M | $116.7M | $165.2M | $163.8M | $180.3M | |
Other Inc / (Exp) | -$84.9M | -$314.2M | -$130.5M | -$474M | -$130.7M | |
Operating Expenses | $97.7M | $124.9M | $177.9M | $190.2M | $214.9M | |
Operating Income | -$16.2M | $567.1M | $1.4B | $1.7B | $2.2B | |
Net Interest Expenses | $70.3M | $57M | $119.3M | $213M | $297.4M | |
EBT. Incl. Unusual Items | -$171.4M | $196M | $1.1B | $1.1B | $1.8B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$1.9M | $7.3M | $147.8M | $170.6M | $351.7M | |
Net Income to Company | -$169.5M | $188.6M | $953.8M | $889.5M | $1.4B | |
Minority Interest in Earnings | -- | -- | -$352.5M | -$368.7M | -$244.1M | |
Net Income to Common Excl Extra Items | -$169.5M | $188.6M | $601.4M | $520.8M | $1.2B | |
Basic EPS (Cont. Ops) | -$0.61 | $0.67 | $2.09 | $1.20 | $1.72 | |
Diluted EPS (Cont. Ops) | -$0.61 | $0.59 | $1.87 | $1.10 | $1.62 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $218.9M | $549.6M | $1.8B | $2.5B | $3.9B | |
EBIT | -$102.2M | $253.3M | $1.2B | $1.3B | $2.1B | |
Revenue (Reported) | $580.1M | $1.2B | $2.4B | $3.7B | $5.1B | |
Operating Income (Reported) | -$16.2M | $567.1M | $1.4B | $1.7B | $2.2B | |
Operating Income (Adjusted) | -$102.2M | $253.3M | $1.2B | $1.3B | $2.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $192.4M | $347.3M | $616.3M | $1.2B | $1.4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $110.3M | $121.6M | $278.2M | $617.9M | $700.5M | |
Gross Profit | $82.1M | $225.6M | $338M | $625.1M | $676M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $25.6M | $31M | $36.6M | $37.4M | $43.1M | |
Other Inc / (Exp) | -$72.9M | -$157M | -$7.4M | -$225.1M | -$52.9M | |
Operating Expenses | $26.4M | $32.9M | $39.8M | $48.9M | $58.3M | |
Operating Income | $55.8M | $192.7M | $298.2M | $576.2M | $617.7M | |
Net Interest Expenses | $17.5M | $13.2M | $36.8M | $72.6M | $73.8M | |
EBT. Incl. Unusual Items | -$34.6M | $22.6M | $254.1M | $278.6M | $490.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $6.8M | $34.3M | $49M | $100.3M | |
Net Income to Company | -$34.6M | $15.8M | $219.8M | $229.6M | $390.6M | |
Minority Interest in Earnings | -- | -- | -$117.7M | -$83M | -$61.3M | |
Net Income to Common Excl Extra Items | -$34.6M | $15.8M | $102.1M | $146.6M | $329.3M | |
Basic EPS (Cont. Ops) | -$0.12 | $0.06 | $0.35 | $0.27 | $0.47 | |
Diluted EPS (Cont. Ops) | -$0.12 | $0.05 | $0.31 | $0.25 | $0.44 | |
Weighted Average Basic Share | $278.9M | $284.9M | $295.9M | $552.5M | $704M | |
Weighted Average Diluted Share | $278.9M | $319.7M | $335.8M | $595.4M | $748.2M | |
EBITDA | $44.8M | $105.2M | $476.3M | $759.8M | $1B | |
EBIT | -$19M | $34.2M | $288M | $349.6M | $562.6M | |
Revenue (Reported) | $192.4M | $347.3M | $616.3M | $1.2B | $1.4B | |
Operating Income (Reported) | $55.8M | $192.7M | $298.2M | $576.2M | $617.7M | |
Operating Income (Adjusted) | -$19M | $34.2M | $288M | $349.6M | $562.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $5.8M | $9.4M | $59.5M | $73.3M | $479.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $41.8M | $1.6M | $1.2M | $3.7M | $7M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $5.2M | $5.9M | $20.6M | $25.5M | $26.3M | |
Total Current Assets | $65.6M | $86.5M | $463.8M | $650.4M | $1.1B | |
Property Plant And Equipment | $3.7B | $3.7B | $8B | $14.1B | $15.6B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $19.2M | $15.9M | $74.6M | $176.1M | $183.1M | |
Total Assets | $3.8B | $3.8B | $8.5B | $15B | $16.9B | |
Accounts Payable | $5.1M | $9.7M | $51.4M | $94.5M | $46M | |
Accrued Expenses | $48.3M | $54.3M | $226.7M | $515.7M | $534.4M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $3.2M | $1.4M | $29.8M | $33M | $57.2M | |
Other Current Liabilities | $18.3M | $36.2M | $13.7M | $41M | $71.7M | |
Total Current Liabilities | $131.9M | $167.9M | $605.6M | $1.2B | $1.3B | |
Long-Term Debt | $1.1B | $825.6M | $2.1B | $3.8B | $4.2B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.2B | $1.1B | $2.8B | $5.7B | $6.4B | |
Common Stock | $29K | $29K | $57K | $77K | $81K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $2.6B | $2.8B | $2.9B | $6.3B | $9.1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | $2.7B | $2.9B | $1.4B | |
Total Equity | $2.6B | $2.8B | $5.7B | $9.2B | $10.5B | |
Total Liabilities and Equity | $3.8B | $3.8B | $8.5B | $15B | $16.9B | |
Cash and Short Terms | $5.8M | $9.4M | $59.5M | $73.3M | $479.3M | |
Total Debt | $1.1B | $825.6M | $2.1B | $3.8B | $4.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $10.9M | $50.6M | $25.6M | $12.7M | $702.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $55.4M | $111M | $207.5M | $1.4M | $932K | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $5.5M | $7M | $8.5M | $32.4M | $23.8M | |
Total Current Assets | $87M | $189.4M | $444M | $607.4M | $1.4B | |
Property Plant And Equipment | $3.7B | $3.7B | $8.2B | $14.3B | $15.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $18.8M | $27.3M | $76.3M | $145.2M | $209.7M | |
Total Assets | $3.8B | $4B | $8.7B | $15.1B | $17.1B | |
Accounts Payable | $19.1M | $38.5M | $136.2M | $43.5M | $88M | |
Accrued Expenses | $74.5M | $69.9M | $203.4M | $424.8M | $467.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $288.6M | |
Current Portion Of Capital Lease Obligations | $2.7M | $1.7M | $35M | $53.2M | $70M | |
Other Current Liabilities | $46.5M | $119.1M | $27.2M | $81.7M | $75.6M | |
Total Current Liabilities | $194.2M | $299.7M | $682M | $1.1B | $1.6B | |
Long-Term Debt | $1.1B | $801.2M | $2B | $3.9B | $3.7B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.3B | $1.2B | $2.9B | $5.7B | $6.3B | |
Common Stock | $29K | $29K | $57K | $78K | $81K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | $2.6B | $2.4B | $1.4B | |
Total Equity | $2.6B | $2.8B | $5.8B | $9.3B | $10.8B | |
Total Liabilities and Equity | $3.8B | $4B | $8.7B | $15.1B | $17.1B | |
Cash and Short Terms | $10.9M | $50.6M | $25.6M | $12.7M | $702.2M | |
Total Debt | $1.1B | $801.2M | $2B | $3.9B | $4B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$685.2M | $138.2M | $749.8M | $879.7M | $1.3B | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | $24.6M | $58.1M | $92.3M | $78.4M | $60.4M | |
Change in Accounts Receivable | $44.6M | -$21.5M | -$66.8M | $36.3M | -$51.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $171.4M | $525.6M | $1.4B | $2.2B | $3.4B | |
Capital Expenditures | $328M | $327.1M | $784M | $1.8B | $3.1B | |
Cash Acquisitions | -- | -- | -$496.7M | $99.8M | -- | |
Cash From Investing | -$326.3M | -$226.5M | -$1.2B | -$1.6B | -$3.1B | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$14.4M | -$141.9M | -$466.9M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $570M | $740M | $1.1B | $2.9B | $3B | |
Long-Term Debt Repaid | -$415M | -$1B | -$1.2B | -$3.2B | -$2.6B | |
Repurchase of Common Stock | -$607K | -$14.5M | -$19M | -$162.4M | -$61M | |
Other Financing Activities | -$6.7M | -$21.1M | -$33.3M | -$109.9M | -$120.4M | |
Cash From Financing | $147.7M | -$297.5M | -$106.6M | -$631.2M | $97.7M | |
Beginning Cash (CF) | $15.5M | $8.3M | $9.9M | $69.9M | $73.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$7.2M | $1.6M | $60M | $3.9M | $405.5M | |
Ending Cash (CF) | $8.3M | $9.9M | $69.9M | $73.9M | $479.3M | |
Levered Free Cash Flow | -$156.6M | $198.6M | $587.7M | $419.8M | $291.3M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$25.1M | $191.8M | $149M | $308.9M | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | $19.1M | -$1.9M | $35.7M | $23M | -- | |
Change in Accounts Receivable | -$18.5M | -$8.9M | -$10.4M | $59.3M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $107.3M | $295M | $448.5M | $938.4M | -- | |
Capital Expenditures | $81M | $145.3M | $406.1M | $682.9M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$80.5M | -$144.5M | -$407.3M | -$675.6M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$32.4M | -$125.8M | -- | |
Special Dividend Paid | -- | -- | $50K | -- | -- | |
Long-Term Debt Issued | $250M | $35M | $470M | $1.6B | -- | |
Long-Term Debt Repaid | -$282.1M | -$35M | -$455M | -$1.6B | -- | |
Repurchase of Common Stock | -- | -- | -$5.9M | -$29.6M | -- | |
Other Financing Activities | -$977K | -$3K | -$25.2M | -$31.1M | -- | |
Cash From Financing | -$33M | $4K | -$48.5M | -$227.7M | -- | |
Beginning Cash (CF) | $13.5M | $51.2M | $26.2M | $13.3M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$6.2M | $150.5M | -$7.3M | $35.2M | -- | |
Ending Cash (CF) | $7.2M | $201.6M | $18.8M | $48.4M | -- | |
Levered Free Cash Flow | $26.3M | $149.6M | $42.4M | $255.5M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$169.5M | $188.6M | $953.8M | $889.5M | $1.4B | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | $33.2M | $62.4M | $90.9M | $70.2M | $67.7M | |
Change in Accounts Receivable | -$11.5M | -$60.3M | -$14.5M | -$47.3M | $47.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $142.9M | $613.4M | $1.6B | $2.4B | $3.7B | |
Capital Expenditures | $206.6M | $364.4M | $1.1B | $2B | $3B | |
Cash Acquisitions | -- | -- | -$496.7M | -- | -- | |
Cash From Investing | -$205.9M | -$264M | -$1.4B | -$1.9B | -$2.8B | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$29.6M | -$213.9M | -$485.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $615M | $635M | $1.1B | $3B | $2.7B | |
Long-Term Debt Repaid | -$520M | -$922.1M | -$1.3B | -$3.1B | -$2.6B | |
Repurchase of Common Stock | -- | -- | -$79.3M | -$132.3M | -$29.6M | |
Other Financing Activities | -$27.1M | -$9M | -$38.1M | -$126.7M | -$122.5M | |
Cash From Financing | $67.3M | -$311.7M | -$261.7M | -$530.2M | -$126.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $4.3M | $37.7M | -$25M | -$12.9M | $689M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$63.7M | $249M | $532.7M | $427M | $623.4M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$59.7M | $207.6M | $368.8M | $538.5M | $390.6M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | $34.1M | $17.3M | $53.6M | $32.6M | $16.9M | |
Change in Accounts Receivable | -$33.5M | -$62.8M | -$11.9M | -$25.8M | $14.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $179.6M | $455.1M | $886.7M | $1.6B | $898M | |
Capital Expenditures | $127.8M | $229.5M | $823.4M | $1.3B | $537.8M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$127.1M | -$228.6M | -$699.4M | -$1.3B | -$361.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$47.6M | -$213M | -$106.1M | |
Special Dividend Paid | -- | -- | $50K | $100K | -- | |
Long-Term Debt Issued | $490M | $170M | $630M | $1.8B | -- | |
Long-Term Debt Repaid | -$522.1M | -$195M | -$715M | -$1.8B | -$175M | |
Repurchase of Common Stock | -- | -$1.3M | -$67.5M | -$61M | -- | |
Other Financing Activities | -$21.6M | -$8.5M | -$38.5M | -$61.3M | -$32.3M | |
Cash From Financing | -$53.6M | -$34.8M | -$238.4M | -$316.5M | -$313.3M | |
Beginning Cash (CF) | $21.8M | $61.1M | $96.1M | $87.1M | $479.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$1.1M | $191.7M | -$51.1M | -$25.4M | $222.9M | |
Ending Cash (CF) | $20.7M | $252.8M | $45M | $61.7M | $702.2M | |
Levered Free Cash Flow | $51.9M | $225.6M | $63.3M | $283.7M | $360.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.